This consumer microbiome startup is betting profits on an AI moonshot
Seed Health became profitable by selling consumer probiotics, and now it's chasing much bigger science, investing in an AI platform for microbiome moonshots.
Source: cnbc.com
Stay updated with breaking news from Eric Topol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Seed Health became profitable by selling consumer probiotics, and now it's chasing much bigger science, investing in an AI platform for microbiome moonshots.
Dr. Eric Topol discusses the promise of “opportunistic” AI, using medical scans for unintended diagnostic purposes.
An article published Wednesday by Nature details how acute loneliness can turn chronic, having disastrous impacts on physical health.
Green bubbles notwithstanding, Apple isn’t a monopolizing boogeyman.
But recently the field has exploded | Technology Quarterly